EGFR and cancer: The proliferation is primarily attributed to kinases known as EGFR-TK (Epidermal Growth Factor Receptor-Tyrosine Kinase), which form part of the family of tyrosine kinases, and are currently considered an important target in the design and development of the new anti-cancer agents.